V. Poletti (Forli, Italy), J. Grutters (Nieuwegein, The Netherlands)
The expression of calgranulin B in idiopathic pulmonary fibrosis
E. Bargagli, C. Olivieri, M. Cintorino, A. Prasse, P. Rottoli (Siena, Italy; Freiburg, Germany)
|   |
Annual changes of serum KL-6 were inversely correlated with those of respiratory function parameters in patients with nonspecific interstitial pneumonia
T. Hirota, T. Harada, T. Matsumoto, T. Akagi, M. Kodama, M. Shiraishi, M. Fujita, K. Watanabe (Fukuoka, Japan)
| |
Serum interleukin 6 levels predict disease progression in scleroderma-associated interstitial lung disease
E. Renzoni, A. de Lauretis, P. Pantelidis, P. Sestini, N. Goh, R. Hoyles, C. Zappala, C. P. Denton, D. J. Abraham, P. Kelleher, R. M. du Bois, D. M. Hansell, S. A. Clark, A. U. Wells (London, United Kingdom; Rome, Siena, Italy; Brisbane, Australia; Denver, United States Of America)
| |
The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases
H. Takizawa, O. Ohbayashi, H. Koyama, T. Kogane, Y. Yamauchi, T. Kohyama, K. Ohta (Kawasaki, Tokyo, Japan)
| |
High level of serum SP-D with normal range of KL-6 predicts a good prognosis of patients with fibrotic changes on HRCT
S. Hisata, Y. Kimura, S. Ono, M. Kobayashi, T. Nukiwa, M. Ebina (Sendai, Japan)
| |
Cykine/receptor inflammatory profile in different types of idiopathic intestitial pneumonias (IIPs). Key role of Fas Ligand recruvation in idiopathic pulmonary fibrosis (IPF)
P. Kopinski, B. Balicka-Slusarczyk, J. Chorostowska-Wynimko, A. Rozy, T. Wandtke, G. Pinis, A. Dyczek, J. Szczeklik (Krakow, Warszawa, Poland)
| |
8-Isoprostane and FeNO levels in IPF and sarcoidosis patients (Preliminary results)
F. Malli, A. Koutsokera, I. Tsilioni, K. Kostikas, K. I. Gourgoulianis, Z. Daniil (Larissa, Greece)
| |
The role of serum cathepsin S levels in sarcoidosis
E. Yamaguchi, N. Yokoe, D. Takahashi, K. Baba, J. Takagi, H. Nakao, M. Yoneda, Y. Ohtsuka, K. Kimura (Nagakute, Iwamizawa, Japan)
| |
Surfactant protein C proprotein, chitotriosidase and RAGE in bronchoalveolar lavage fluid of children with sarcoidosis
L. Guillot, G. Thouvenin, F. Flamein, C. Caillaud, K. Chadelat, C. Charlier, J. Beucher, H. Corvol, A. Clement, R. Epaud (Paris, France)
| |
Is YKL-40 a prognostic marker in sarcoidosis?
C. B. Svendsen, N. Milman, J. S. Johansen (Copenhagen, Denmark)
| |
Increased nitric oxide synthase isoforms, endothelin 1 and apoptosis varied in lungs from patients with (SSc) and had impact on pulmonary function tests
A. C. Aguiar Junior, S. Fernezlian, V. L. Capelozzi, E. R. Parra (Brazil)
| |
Markers of inflammation and pulmonary function (PF) in sarcoidosis
M. Bednarek, A. Goljan-Geremek, P. Boros, E. Puscinska, D. Korzybski, M. Czystowska, M. Filewska, U. Demkow, D. Gorecka (Warsaw, Poland)
| |
Additional test in diagnosis of tuberculosis and sarcoidosis
H. Baradzina, I. Kotovich, A. Tahanovich, V. Borshevsky (Minsk, Belarus)
| |
Serum and BALF levels of YKL-40 in patients with alveolar proteinosis
F. Bonella, S. U. Sixt, M. Cai, S. Ohshimo, J. Guzman, U. Costabel (Essen, Düsseldorf, Germany; , Japan)
| |
Exercise and inflammation in sarcoidosis
A. Goljan-Geremek, U. Demkow, M. Bednarek, M. Czystowska, E. Puscinska, D. Korzybski, M. Kram, M. Filewska, D. Górecka (Warsaw, Poland)
| |
Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis
F. Drakopanagiotakis, A. Xifteri, E. Tsiambas, D. Mermigkis, A. Karameris, C. Tsakanika, V. Polychronopoulos, D. Bouros (Athens, Alexandroupoli, Greece)
| |
Endosomal Toll-like receptors (TLR3 and 9) are overexpressed in bronchoalveolar lavage fluid of patients with lung cancer: Preliminary results
K. Samara, K. Antoniou, E. Vassalou, K. Karagiannis, R. Lymbouridou, N. Siafakas (Heraklion, Greece)
| |